189 related articles for article (PubMed ID: 17670797)
1. Cell-penetrating peptides as transporters for morpholino oligomers: effects of amino acid composition on intracellular delivery and cytotoxicity.
Wu RP; Youngblood DS; Hassinger JN; Lovejoy CE; Nelson MH; Iversen PL; Moulton HM
Nucleic Acids Res; 2007; 35(15):5182-91. PubMed ID: 17670797
[TBL] [Abstract][Full Text] [Related]
2. Stability of cell-penetrating peptide-morpholino oligomer conjugates in human serum and in cells.
Youngblood DS; Hatlevig SA; Hassinger JN; Iversen PL; Moulton HM
Bioconjug Chem; 2007; 18(1):50-60. PubMed ID: 17226957
[TBL] [Abstract][Full Text] [Related]
3. Delivery of steric block morpholino oligomers by (R-X-R)4 peptides: structure-activity studies.
Abes R; Moulton HM; Clair P; Yang ST; Abes S; Melikov K; Prevot P; Youngblood DS; Iversen PL; Chernomordik LV; Lebleu B
Nucleic Acids Res; 2008 Nov; 36(20):6343-54. PubMed ID: 18796528
[TBL] [Abstract][Full Text] [Related]
4. Vectorization of morpholino oligomers by the (R-Ahx-R)4 peptide allows efficient splicing correction in the absence of endosomolytic agents.
Abes S; Moulton HM; Clair P; Prevot P; Youngblood DS; Wu RP; Iversen PL; Lebleu B
J Control Release; 2006 Dec; 116(3):304-13. PubMed ID: 17097177
[TBL] [Abstract][Full Text] [Related]
5. Cell-penetrating peptide-morpholino conjugates alter pre-mRNA splicing of DMD (Duchenne muscular dystrophy) and inhibit murine coronavirus replication in vivo.
Moulton HM; Fletcher S; Neuman BW; McClorey G; Stein DA; Abes S; Wilton SD; Buchmeier MJ; Lebleu B; Iversen PL
Biochem Soc Trans; 2007 Aug; 35(Pt 4):826-8. PubMed ID: 17635157
[TBL] [Abstract][Full Text] [Related]
6. Arginine-rich peptide conjugation to morpholino oligomers: effects on antisense activity and specificity.
Nelson MH; Stein DA; Kroeker AD; Hatlevig SA; Iversen PL; Moulton HM
Bioconjug Chem; 2005; 16(4):959-66. PubMed ID: 16029037
[TBL] [Abstract][Full Text] [Related]
7. Cellular uptake of antisense morpholino oligomers conjugated to arginine-rich peptides.
Moulton HM; Nelson MH; Hatlevig SA; Reddy MT; Iversen PL
Bioconjug Chem; 2004; 15(2):290-9. PubMed ID: 15025524
[TBL] [Abstract][Full Text] [Related]
8. Helix-Stabilized Cell-Penetrating Peptides for Delivery of Antisense Morpholino Oligomers: Relationships among Helicity, Cellular Uptake, and Antisense Activity.
Takada H; Tsuchiya K; Demizu Y
Bioconjug Chem; 2022 Jul; 33(7):1311-1318. PubMed ID: 35737901
[TBL] [Abstract][Full Text] [Related]
9. Live-cell analysis of cell penetration ability and toxicity of oligo-arginines.
Tünnemann G; Ter-Avetisyan G; Martin RM; Stöckl M; Herrmann A; Cardoso MC
J Pept Sci; 2008 Apr; 14(4):469-76. PubMed ID: 18069724
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics, biodistribution, stability and toxicity of a cell-penetrating peptide-morpholino oligomer conjugate.
Amantana A; Moulton HM; Cate ML; Reddy MT; Whitehead T; Hassinger JN; Youngblood DS; Iversen PL
Bioconjug Chem; 2007; 18(4):1325-31. PubMed ID: 17583927
[TBL] [Abstract][Full Text] [Related]
11. Arginine-rich cell penetrating peptides: design, structure-activity, and applications to alter pre-mRNA splicing by steric-block oligonucleotides.
Abes R; Arzumanov A; Moulton H; Abes S; Ivanova G; Gait MJ; Iversen P; Lebleu B
J Pept Sci; 2008 Apr; 14(4):455-60. PubMed ID: 18236382
[TBL] [Abstract][Full Text] [Related]
12. Arginine-rich cell-penetrating peptides facilitate delivery of antisense oligomers into murine leukocytes and alter pre-mRNA splicing.
Marshall NB; Oda SK; London CA; Moulton HM; Iversen PL; Kerkvliet NI; Mourich DV
J Immunol Methods; 2007 Aug; 325(1-2):114-26. PubMed ID: 17673254
[TBL] [Abstract][Full Text] [Related]
13. Improved cellular uptake of antisense peptide nucleic acids by conjugation to a cell-penetrating peptide and a lipid domain.
Shiraishi T; Nielsen PE
Methods Mol Biol; 2011; 751():209-21. PubMed ID: 21674333
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of cell-penetrating peptides (CPPs) as vehicles for intracellular delivery of antisense peptide nucleic acid (PNA).
Bendifallah N; Rasmussen FW; Zachar V; Ebbesen P; Nielsen PE; Koppelhus U
Bioconjug Chem; 2006; 17(3):750-8. PubMed ID: 16704214
[TBL] [Abstract][Full Text] [Related]
15. Cell penetrating peptide conjugates of steric block oligonucleotides.
Lebleu B; Moulton HM; Abes R; Ivanova GD; Abes S; Stein DA; Iversen PL; Arzumanov AA; Gait MJ
Adv Drug Deliv Rev; 2008 Mar; 60(4-5):517-29. PubMed ID: 18037527
[TBL] [Abstract][Full Text] [Related]
16. Insights into the cellular trafficking of splice redirecting oligonucleotides complexed with chemically modified cell-penetrating peptides.
Hassane FS; Abes R; El Andaloussi S; Lehto T; Sillard R; Langel U; Lebleu B
J Control Release; 2011 Jul; 153(2):163-72. PubMed ID: 21536086
[TBL] [Abstract][Full Text] [Related]
17. Gene-specific effects of antisense phosphorodiamidate morpholino oligomer-peptide conjugates on Escherichia coli and Salmonella enterica serovar typhimurium in pure culture and in tissue culture.
Tilley LD; Hine OS; Kellogg JA; Hassinger JN; Weller DD; Iversen PL; Geller BL
Antimicrob Agents Chemother; 2006 Aug; 50(8):2789-96. PubMed ID: 16870773
[TBL] [Abstract][Full Text] [Related]
18. Induction of splice correction by cell-penetrating peptide nucleic acids.
El-Andaloussi S; Johansson HJ; Lundberg P; Langel U
J Gene Med; 2006 Oct; 8(10):1262-73. PubMed ID: 16900561
[TBL] [Abstract][Full Text] [Related]
19. Antisense peptide-phosphorodiamidate morpholino oligomer conjugate: dose-response in mice infected with Escherichia coli.
Tilley LD; Mellbye BL; Puckett SE; Iversen PL; Geller BL
J Antimicrob Chemother; 2007 Jan; 59(1):66-73. PubMed ID: 17079242
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and splice-redirecting activity of branched, arginine-rich peptide dendrimer conjugates of peptide nucleic acid oligonucleotides.
Saleh AF; Arzumanov A; Abes R; Owen D; Lebleu B; Gait MJ
Bioconjug Chem; 2010 Oct; 21(10):1902-11. PubMed ID: 20879728
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
